We are proud to announce the successful installation and commissioning of a new LCTR® system at AstraZeneca’s Macclesfield site.

A heartfelt thank you to the AstraZeneca team for their trust and collaboration, as well as to all colleagues at Laminar Co., Ltd. and our partners at Analytik who contributed to making this project a success.

We believe this new reactor system installation at a leading pharmaceutical company like AstraZeneca represents a significant milestone for Laminar’s LCTR® series, whose application areas continue to expand.

Laminar is committed to continuously supporting our users in achieving the best results. We wish our AstraZeneca users every success with their projects using our Taylor flow reactor.